SlideShare a Scribd company logo
1 of 55
Download to read offline
Major Advisor : Dr. K.
Jayakumar
Speaker : Amol R. Padol
CREDIT SEMINAR-I
INTRODUCTIONINTRODUCTION
OECD ???
o an intergovernmental organisation.
o Representatives of 30 industrialised countries in North
America, Europe, Pacific and the European Commission.
o To co-ordinate and harmonize policies, discuss issues of
mutual concern, and work together to respond to
international problems.
o Environmental Health and Safety Division.
o The Principles of GLP have been developed to
promote the quality and validity of test data used for
determining the safety of chemicals and chemical
products (Schechtman, 2007)
Good Laboratory PracticeGood Laboratory Practice
o A quality system concerned with the organisational
process and the conditions under which non-clinical
health and environmental safety studies are planned,
performed, monitored, recorded, archived and
reported.
(OECD/ENV/MC/CHEM,1998)
o Its principles are required to be followed by test
facilities carrying out studies to be submitted to
national authorities.
o Common principles for GLP
facilitate the exchange of
information and prevent the
emergence of non-tariff
barriers to trade.
(Berend, 2002)
o The issue of data quality has an important
international dimension.
o If regulatory authorities in countries can rely on safety
test data developed abroad, duplicative testing can be
avoided.
HISTORYHISTORY
o The GLP regulations for non-clinical laboratory studies
published by the US-FDA in 1976 (Baldeshwiler, 2003).
o The OECD Principles of GLP were first developed by an
Expert Group on GLP established in 1978 under the
Special Programme on the Control of Chemicals.
o Principles of GLP were adopted by the OECD in 1981.
o Expert Group was established in 1995 to develop a
proposal to revise the Principles of GLP.
o The Revised OECD Principles of GLP were reviewed in
the relevant policy bodies of the Organisation and were
adopted by Council on 26 November, 1997.
o Indian GLP Compliance Monitoring Authority - April,
2002.
SCOPESCOPE
 Principles of GLP should be applied to the non-clinical
safety testing of test items contained in,
 Pharmaceutical products
 Pesticide products
 Cosmetic products
 Veterinary drugs
 Food and feed additives
 Industrial chemicals.
o Test items: synthetic chemicals, natural or biological
origin and, may be living organisms.
o Safety studies covered by the Principles of GLP include
work conducted in the laboratory, in greenhouses, and
in the field (Jena et al ., 2009)
o Principles of GLP apply to all non-clinical health and
environmental safety studies required by regulations for
the purpose of registration.
GOOD LABORATORY PRACTICE
“PRINCIPLES”
Key Personnel in GLP
Test Facility Management
o The person(s) who has the authority and formal
responsibility for the organisation and functioning of the
test facility.
Responsibilities
o Maintenance of a record of the qualifications, training,
experience and job description for each professional and
technical individual.
o Appropriate and technically valid SOPs are established
and followed.
o Quality Assurance Programme is being performed in
accordance with the Principles of GLP.
o Individual with the appropriate qualifications, training,
and experience is designated by the management as the
Study Director before the study is initiated.
o In the event of a multi-site study, a Principal Investigator
is designated.
o Test Facility Management should ensure the
documented approval of the study plan by the Study
Director.
o Ensure that the SD has made the approved study plan
available to the QA personnel.
o An individual is identified as responsible for the
management of the archive(s).
o For a multi-site study clear lines of communication
should exist between the SD, Principal Investigator(s),
the QAP(s) and study personnel.
o Computerised systems should be validated, operated
and maintained in accordance with Principles of GLP
(Udaka and Horii, 1985)
Study Director
o The individual responsible for the
overall conduct of the nonclinical
health and environmental safety
study.
o The single point of study control.
o Approve the study plan and any amendments by dated
signature.
o SD should ensure that the QA personnel have a copy of
the study plan and any amendments.
o Study plans (and amendments) and SOPs are available
to study personnel.
Responsibilities of SD
o SD should ensure that all raw data generated are fully
documented and recorded.
o Computerised systems used in the study should be
validated (Taylor, 1984)
o SD should sign and date the final report to indicate
acceptance of responsibility for the validity of the data.
o SD should ensure that after
completion of the study,
 the study plan
 the final report
 raw data
 supporting material
are archived.
Principal Investigator
o an individual who, for a multi-
site study, acts on behalf of the
SD and has defined
responsibility for delegated
phases of the study.
o The PI should ensure that the
delegated phases of the study
are conducted in accordance
with the Principles of GLP.
Responsibilities of Study Personnel
o Knowledgeable in those parts of the Principles of GLP
which are applicable to their involvement in the study.
o Access to the study plan and appropriate SOPs.
o Any deviation from these instructions should be
documented and communicated directly to the SD, or
the Principal Investigator.
o Responsible for recording raw data
promptly and accurately and for the
quality of the data.
o Study personnel should exercise
health precautions to minimise risk
to themselves and to ensure the
integrity of the study
(Schechtman, 2007).
Quality Assurance
Programme
o "an internal control system designed to ascertain that
the study is in compliance" with the Principles of GLP.
o The test facility should have a documented QAP.
o An individual or individuals designated by
management, who are familiar with the test
procedures (Hughes, 1999)
o should not be involved in the conduct of the study
being assured (Becker et al., 2009)
o Maintain copies of all approved study plans and SOPs.
o Verify that the study plan contains the information
required for compliance with the Principles of GLP.
o Conduct inspections to determine that all studies are
conducted in accordance with the Principles of GLP.
(Hughes, 1999)
Responsibilities of the QA-
Personnel
o Inspect the final reports to confirm that,
 the methods, procedures and observations are
accurately and completely described.
 reported results accurately and completely reflect the
raw data of the studies.
o Promptly report any inspection results in writing to
management and to the SD, or Principal Investigator(s).
o Prepare and sign a statement, which specifies types of
inspections and their dates, including the phase(s) of the
study inspected.
Facilities
o Suitable size, construction and location to meet the
requirements of the study.
o Adequate degree of separation of the different activities
to assure the proper conduct of each study
(Garner and Barge, 1989)
Facilities for Handling Test and
Reference Items
o Separate areas for receipt and storage of the test and
reference items, and mixing of the test items with a
vehicle.
o Storage areas for the test items should be separate from
areas containing the test systems.
o Storage areas should be adequate to preserve identity,
concentration, purity, and stability.
Archive Facilities
o Archive facilities should be provided for the secure
storage and retrieval of study plans, raw data, final
reports, samples of test items and specimens.
Archive design and archive
conditions should protect
contents from untimely
deterioration (Udaka and Horii,
1985)
Waste Disposal
o Handling and disposal of wastes
should be carried out in such a way
as not to jeopardize the integrity of
studies.
o Provision for appropriate
collection, storage and disposal
facilities, and decontamination and
transportation procedures.
Apparatus, Material and Reagents
o Apparatus should be suitably located and of
appropriate design and adequate capacity.
o Periodically inspected, cleaned, maintained, and
calibrated according to SOPs.
o Apparatus and materials used in a study should not
interfere adversely with the test systems
(Stevenson, 1992)
o Chemicals, reagents, and solutions should be labelled to
indicate identity, expiry date and specific storage
instructions.
o Information concerning source, preparation date and
stability should be available.
Test SystemsTest Systems
o any biological, chemical or physical
system or a combination thereof
used in a study.
Physical/ChemicalPhysical/Chemical
 Location
 Design
 Capacity.
o Proper conditions should be established and maintained
for the storage, housing, handling and care of biological
test systems.
o Newly received animal and plant test systems should be
isolated until their health status has been evaluated.
o Acclimatised to the test environment.
Biologica
l
Standard Operating
Procedures
o A test facility should have written
SOPs approved by test facility
management.
o Language interpretable to those who
are going to use them (Federick, 2006)
Documented procedures which
describe how to perform tests or
activities normally not specified in
detail in study plans or test guidelines.
o Deviations from SOPs should be
documented and acknowledged by the
SD or the Principal Investigator.
o Published text books, analytical methods,
articles and manuals -supplements to the
SOPs.
o Reviewed regularly.
o SOPs should be available for the following categories of
activities:
 Test and Reference Items
 Apparatus, Materials and Reagents
 Record Keeping, Reporting, Storage, and Retrieval
 Test System
 Quality Assurance Procedures.
Content of the Study Plan
o Identification of the study, the test item and reference
item.
o Information concerning the sponsor and the test
facility.
o Dates
o Test Methods
o Records
Conduct of the Study
o A unique identification should be given to each study,
all items concerning this study should carry this
identification (Royal, 1994)
o Specimens from the study should be identified to
confirm their origin.
o Conducted in accordance with the study plan.
o Data generated should be recorded directly, promptly,
accurately and signed and dated.
o Any change in the raw data should indicate the reason
for change and should be dated and signed by the
individual making the change.
o Computerised system should always provide for the
retention of full audit trails to show all changes to the
data without obscuring the original data.
Reporting of Study
Results
o The final report should be signed and dated by the SD
to indicate acceptance of responsibility for the validity
of the data.
o The extent of compliance with the principles of GLP
should be indicated.
o Amendments should clearly specify the reason for the
corrections or additions and should be signed and
dated by the SD
(Ranade, 2007)
Content of the Final
Report
o The final report should include,
 Identification of the Study, the Test Item and
Reference Item.
 Information concerning the Sponsor and the Test
Facility.
 Dates
 QAP statement
 Description of Test Methods
 Results
 Storage (study plan, test and reference items, specimens, raw
data)
Mutual Acceptance of Data
o Testing of chemicals is labour-intensive and expensive,
and testing the same chemical in several countries adds
to the cost in time, resources and laboratory animals.
o To relieve some of this burden, the OECD Council
adopted the concept of MAD in 1981.
o Mutual Acceptance of Data:
“Data generated in a member country in accordance
with OECD Test Guidelines and Principles of GLP shall
be accepted in other member countries for assessment
purposes and other uses relating to the protection of
human health and the environment.”
(Turnheim , 2008)
o OECD Council sets out a step-wise procedure for non-
OECD countries with a major chemical industry to take
part in the work of OECD (Sasaki et al., 2009)
o This leads to full membership in the part of OECD
related to the MAD.
o South Africa was the first non-OECD country to have
completed this process and to have been invited to join
the system as a full member.
o Slovenia and Israel - full members.
o Argentina, Brazil, India (2003) , Malaysia and
Singapore are the provisional adherents.
o The provisional adherence procedures have begun for
Thailand.
National GLP Compliance Monitoring
Authority (NGCMA)
o April, 2002
o Department of Science and Technology (DST).
o Provisional Member of the OECD for GLP.
o Head, National GLP Programme has been nominated
by the Department as an Observer to the OECD’s
Working Group on GLP.
o functions as per OECD Norms & Principles and efforts
are being made to achieve OECD recognition, so that
India acquires full-member status in OECD (Stanley, 2009)
There is still long way to go……………..!
CONCLUSIONCONCLUSION
o The purpose of GLP is to assure the quality and integrity
of data submitted in support of the safety of regulated
products.
o Protocols, SOPs, adequate facilities, and equipments,
identification of test substance, proper animal care,
accurate recording of observations and adequate
reporting of results are basic necessities for the conduct
of high quality valid toxicity study.
o Test results obtained in compliance with GLP are to be
mutually accepted by the health authorities and
environment authorities of the OECD member states.
Therefore, multiple testing can be avoided.
Oecd principles of GLP

More Related Content

What's hot

Schedule y for toxicity studies
Schedule y  for toxicity studiesSchedule y  for toxicity studies
Schedule y for toxicity studiesKrushangiShah233
 
Alternative methods to animal toxicity testing
Alternative methods to animal toxicity testingAlternative methods to animal toxicity testing
Alternative methods to animal toxicity testingSanchit Dhankhar
 
Assignment on Regulatory Prespectives of Clinical Trials
Assignment on Regulatory Prespectives of Clinical TrialsAssignment on Regulatory Prespectives of Clinical Trials
Assignment on Regulatory Prespectives of Clinical TrialsDeepak Kumar
 
Regulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ichRegulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ichAnimatedWorld
 
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptxTOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptxAnmolkanda06
 
Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3
Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3
Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3SONALPANDE5
 
Safety pharmacology studies
Safety pharmacology studies Safety pharmacology studies
Safety pharmacology studies Santosh Sai
 
Reproductive toxicology studies ACCORDING TO OECD guidlines 422
Reproductive toxicology  studies ACCORDING TO OECD guidlines 422 Reproductive toxicology  studies ACCORDING TO OECD guidlines 422
Reproductive toxicology studies ACCORDING TO OECD guidlines 422 SONALPANDE5
 
Alternative methods to animal toxicity testing
Alternative methods to        animal toxicity testingAlternative methods to        animal toxicity testing
Alternative methods to animal toxicity testingSachin Sharma
 
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptx
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptxTEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptx
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptxashharnomani
 
Acute dermal irritation/corrosion: OECD 404
Acute dermal irritation/corrosion: OECD 404Acute dermal irritation/corrosion: OECD 404
Acute dermal irritation/corrosion: OECD 404Dr Ajay Mandal
 
Toxicity Studies : Acute Eye Irritation, Dermal Irritation
Toxicity Studies : Acute Eye Irritation, Dermal IrritationToxicity Studies : Acute Eye Irritation, Dermal Irritation
Toxicity Studies : Acute Eye Irritation, Dermal IrritationShubhu20
 
Toxicology & Regulatory Guidelines for Conducting Toxicity Study
Toxicology & Regulatory Guidelines for Conducting Toxicity StudyToxicology & Regulatory Guidelines for Conducting Toxicity Study
Toxicology & Regulatory Guidelines for Conducting Toxicity StudyJanhaviBurade
 
Good Laboratory Practice(GLP) by Kashikant Yadav
 Good Laboratory Practice(GLP) by Kashikant Yadav Good Laboratory Practice(GLP) by Kashikant Yadav
Good Laboratory Practice(GLP) by Kashikant YadavKashikant Yadav
 
Origin and principles of international conference on harmonization- Good clin...
Origin and principles of international conference on harmonization- Good clin...Origin and principles of international conference on harmonization- Good clin...
Origin and principles of international conference on harmonization- Good clin...AbhishekJoshi312
 
regulatory perspectives of clinical trails
regulatory perspectives of clinical trails regulatory perspectives of clinical trails
regulatory perspectives of clinical trails Pankaj Maurya
 
OECD Principle of GLP (1).pptx
OECD Principle of GLP (1).pptxOECD Principle of GLP (1).pptx
OECD Principle of GLP (1).pptxapoorvpatil5
 
List of studies needed for IND submission
List of studies needed for IND submissionList of studies needed for IND submission
List of studies needed for IND submissionShivanshu Bajaj
 

What's hot (20)

Schedule y for toxicity studies
Schedule y  for toxicity studiesSchedule y  for toxicity studies
Schedule y for toxicity studies
 
Ind enabling studies.
Ind enabling studies.Ind enabling studies.
Ind enabling studies.
 
Alternative methods to animal toxicity testing
Alternative methods to animal toxicity testingAlternative methods to animal toxicity testing
Alternative methods to animal toxicity testing
 
Assignment on Regulatory Prespectives of Clinical Trials
Assignment on Regulatory Prespectives of Clinical TrialsAssignment on Regulatory Prespectives of Clinical Trials
Assignment on Regulatory Prespectives of Clinical Trials
 
Regulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ichRegulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ich
 
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptxTOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
 
Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3
Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3
Female reproductive toxicity studies acoording to SECHDULE Y AND ICH S5R3
 
Safety pharmacology studies
Safety pharmacology studies Safety pharmacology studies
Safety pharmacology studies
 
Reproductive toxicology studies ACCORDING TO OECD guidlines 422
Reproductive toxicology  studies ACCORDING TO OECD guidlines 422 Reproductive toxicology  studies ACCORDING TO OECD guidlines 422
Reproductive toxicology studies ACCORDING TO OECD guidlines 422
 
Alternative methods to animal toxicity testing
Alternative methods to        animal toxicity testingAlternative methods to        animal toxicity testing
Alternative methods to animal toxicity testing
 
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptx
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptxTEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptx
TEST ITEM CHARACTERIZATION IN REGULATORY TOXICOLOGY STUDIES.pptx
 
Acute dermal irritation/corrosion: OECD 404
Acute dermal irritation/corrosion: OECD 404Acute dermal irritation/corrosion: OECD 404
Acute dermal irritation/corrosion: OECD 404
 
Toxicity Studies : Acute Eye Irritation, Dermal Irritation
Toxicity Studies : Acute Eye Irritation, Dermal IrritationToxicity Studies : Acute Eye Irritation, Dermal Irritation
Toxicity Studies : Acute Eye Irritation, Dermal Irritation
 
Toxicology & Regulatory Guidelines for Conducting Toxicity Study
Toxicology & Regulatory Guidelines for Conducting Toxicity StudyToxicology & Regulatory Guidelines for Conducting Toxicity Study
Toxicology & Regulatory Guidelines for Conducting Toxicity Study
 
Good Laboratory Practice(GLP) by Kashikant Yadav
 Good Laboratory Practice(GLP) by Kashikant Yadav Good Laboratory Practice(GLP) by Kashikant Yadav
Good Laboratory Practice(GLP) by Kashikant Yadav
 
Origin and principles of international conference on harmonization- Good clin...
Origin and principles of international conference on harmonization- Good clin...Origin and principles of international conference on harmonization- Good clin...
Origin and principles of international conference on harmonization- Good clin...
 
regulatory perspectives of clinical trails
regulatory perspectives of clinical trails regulatory perspectives of clinical trails
regulatory perspectives of clinical trails
 
OECD Principle of GLP (1).pptx
OECD Principle of GLP (1).pptxOECD Principle of GLP (1).pptx
OECD Principle of GLP (1).pptx
 
Kk Test item characterization
Kk Test item characterizationKk Test item characterization
Kk Test item characterization
 
List of studies needed for IND submission
List of studies needed for IND submissionList of studies needed for IND submission
List of studies needed for IND submission
 

Viewers also liked

Corporate governance oecd principles sep 2015
Corporate governance oecd principles sep 2015Corporate governance oecd principles sep 2015
Corporate governance oecd principles sep 2015Ankush Thathai
 
Good Laboratory Practices ppt
Good Laboratory Practices pptGood Laboratory Practices ppt
Good Laboratory Practices pptKrushna Yadav D K
 
International Guidelines and Regulatory Agencies for Toxicity Studies
International Guidelines and Regulatory Agencies for Toxicity StudiesInternational Guidelines and Regulatory Agencies for Toxicity Studies
International Guidelines and Regulatory Agencies for Toxicity StudiesSuneal Saini
 
Overview Of Corporate Governance
Overview Of Corporate GovernanceOverview Of Corporate Governance
Overview Of Corporate GovernanceElijah Ezendu
 
OECD Guidelines in Practice 2011/2012
OECD Guidelines in Practice 2011/2012OECD Guidelines in Practice 2011/2012
OECD Guidelines in Practice 2011/2012FIAN Norge
 
International Regulatory Cooperation The regulatory perspective
International Regulatory Cooperation The regulatory perspectiveInternational Regulatory Cooperation The regulatory perspective
International Regulatory Cooperation The regulatory perspectiveOECD Governance
 
Corporate governance
Corporate governanceCorporate governance
Corporate governancegreenslide
 
OECD and genotoxicity guidelines
OECD and genotoxicity guidelinesOECD and genotoxicity guidelines
OECD and genotoxicity guidelinesSandhya Talla
 
Financial Accounting
Financial AccountingFinancial Accounting
Financial AccountingUltraspectra
 
1. intro to financial accounting mba
1. intro to financial accounting mba 1. intro to financial accounting mba
1. intro to financial accounting mba Karan Kukreja
 
Financial accounting-
Financial accounting-Financial accounting-
Financial accounting-Khalid Aziz
 
Thank You Slideshare
Thank You SlideshareThank You Slideshare
Thank You Slidesharerajnish kumar
 
Corporate governance
Corporate governanceCorporate governance
Corporate governanceJatin Patel
 
Good laboratory practices
Good laboratory practicesGood laboratory practices
Good laboratory practicesSyeda Abeer
 

Viewers also liked (20)

Corporate governance oecd principles sep 2015
Corporate governance oecd principles sep 2015Corporate governance oecd principles sep 2015
Corporate governance oecd principles sep 2015
 
Good Laboratory Practices ppt
Good Laboratory Practices pptGood Laboratory Practices ppt
Good Laboratory Practices ppt
 
International Guidelines and Regulatory Agencies for Toxicity Studies
International Guidelines and Regulatory Agencies for Toxicity StudiesInternational Guidelines and Regulatory Agencies for Toxicity Studies
International Guidelines and Regulatory Agencies for Toxicity Studies
 
Overview Of Corporate Governance
Overview Of Corporate GovernanceOverview Of Corporate Governance
Overview Of Corporate Governance
 
GOOD LABORATORY PRACTICES
GOOD LABORATORY PRACTICES GOOD LABORATORY PRACTICES
GOOD LABORATORY PRACTICES
 
ACUTE, SUB ACUTE & CHRONIC TOXICOLOGICAL STUDIES
ACUTE, SUB ACUTE & CHRONIC TOXICOLOGICAL STUDIESACUTE, SUB ACUTE & CHRONIC TOXICOLOGICAL STUDIES
ACUTE, SUB ACUTE & CHRONIC TOXICOLOGICAL STUDIES
 
OECD Sovereign Borrowing Outlook - 2014 Highlights
OECD Sovereign Borrowing Outlook - 2014 HighlightsOECD Sovereign Borrowing Outlook - 2014 Highlights
OECD Sovereign Borrowing Outlook - 2014 Highlights
 
OECD Guidelines in Practice 2011/2012
OECD Guidelines in Practice 2011/2012OECD Guidelines in Practice 2011/2012
OECD Guidelines in Practice 2011/2012
 
International Regulatory Cooperation The regulatory perspective
International Regulatory Cooperation The regulatory perspectiveInternational Regulatory Cooperation The regulatory perspective
International Regulatory Cooperation The regulatory perspective
 
Oecd guidline
Oecd guidlineOecd guidline
Oecd guidline
 
Oecd guide line2
Oecd guide line2Oecd guide line2
Oecd guide line2
 
Corporate governance
Corporate governanceCorporate governance
Corporate governance
 
OECD and genotoxicity guidelines
OECD and genotoxicity guidelinesOECD and genotoxicity guidelines
OECD and genotoxicity guidelines
 
Financial Accounting
Financial AccountingFinancial Accounting
Financial Accounting
 
1. intro to financial accounting mba
1. intro to financial accounting mba 1. intro to financial accounting mba
1. intro to financial accounting mba
 
Financial accounting-
Financial accounting-Financial accounting-
Financial accounting-
 
Thank You Slideshare
Thank You SlideshareThank You Slideshare
Thank You Slideshare
 
Corporate governance
Corporate governanceCorporate governance
Corporate governance
 
Digitalisation and the Future of Work (Part 1) - October 2016 Meeting of the ...
Digitalisation and the Future of Work (Part 1) - October 2016 Meeting of the ...Digitalisation and the Future of Work (Part 1) - October 2016 Meeting of the ...
Digitalisation and the Future of Work (Part 1) - October 2016 Meeting of the ...
 
Good laboratory practices
Good laboratory practicesGood laboratory practices
Good laboratory practices
 

Similar to Oecd principles of GLP

OECD Principle Of Good Laboratory Practice (GLP).pptx
OECD Principle Of Good Laboratory Practice (GLP).pptxOECD Principle Of Good Laboratory Practice (GLP).pptx
OECD Principle Of Good Laboratory Practice (GLP).pptxSIRAJUDDIN MOLLA
 
Good laboratory practices (GLP)
Good laboratory practices (GLP)Good laboratory practices (GLP)
Good laboratory practices (GLP)DIVYA BHARDWAJ
 
Good Laboratory Practice
Good Laboratory PracticeGood Laboratory Practice
Good Laboratory Practicekaushiktheone
 
Good laboratory practices
Good laboratory practicesGood laboratory practices
Good laboratory practicessuraj p rajan
 
Good Laboratory Practices Mubashir Maqbool
Good Laboratory Practices Mubashir MaqboolGood Laboratory Practices Mubashir Maqbool
Good Laboratory Practices Mubashir MaqboolMUBASHIR WANI
 
GOOD LABORATORY PRACTICES
GOOD LABORATORY PRACTICES GOOD LABORATORY PRACTICES
GOOD LABORATORY PRACTICES anubhavdubey18
 
Good laboratory practices.pptx
Good laboratory practices.pptxGood laboratory practices.pptx
Good laboratory practices.pptxSayaliGanjiwale
 
good laboratory practices..docx
good laboratory practices..docxgood laboratory practices..docx
good laboratory practices..docxKalloliChatterjee
 
Good Laboratory Practice (GLP)
Good Laboratory Practice (GLP) Good Laboratory Practice (GLP)
Good Laboratory Practice (GLP) Rana Rana
 
Good Laboratory Practices .pptx
Good Laboratory Practices .pptxGood Laboratory Practices .pptx
Good Laboratory Practices .pptxArchna53
 
Good Laboratory Practice
Good Laboratory PracticeGood Laboratory Practice
Good Laboratory PracticeSurbhiSharma196
 
Good laboratory practices (GLP) himanshu
Good laboratory practices (GLP) himanshuGood laboratory practices (GLP) himanshu
Good laboratory practices (GLP) himanshuhimanshu kamboj
 
Good Laboratory Practices Pharmaceutical Quality Assurance
Good Laboratory Practices Pharmaceutical Quality AssuranceGood Laboratory Practices Pharmaceutical Quality Assurance
Good Laboratory Practices Pharmaceutical Quality AssuranceShrikantKavitake1
 
OECD PRINCIPLES OF GLP- AKSHAY S.pptx
OECD PRINCIPLES OF GLP- AKSHAY S.pptxOECD PRINCIPLES OF GLP- AKSHAY S.pptx
OECD PRINCIPLES OF GLP- AKSHAY S.pptxSiddharthShekharSing4
 

Similar to Oecd principles of GLP (20)

Glp seminar
Glp  seminarGlp  seminar
Glp seminar
 
OECD Principle Of Good Laboratory Practice (GLP).pptx
OECD Principle Of Good Laboratory Practice (GLP).pptxOECD Principle Of Good Laboratory Practice (GLP).pptx
OECD Principle Of Good Laboratory Practice (GLP).pptx
 
Good laboratory practices (GLP)
Good laboratory practices (GLP)Good laboratory practices (GLP)
Good laboratory practices (GLP)
 
GLP and Schedule 1
GLP and Schedule 1GLP and Schedule 1
GLP and Schedule 1
 
What is glp
What is glpWhat is glp
What is glp
 
Good Laboratory Practice
Good Laboratory PracticeGood Laboratory Practice
Good Laboratory Practice
 
Glp ppt
Glp pptGlp ppt
Glp ppt
 
Good laboratory practices
Good laboratory practicesGood laboratory practices
Good laboratory practices
 
Good Laboratory Practices Mubashir Maqbool
Good Laboratory Practices Mubashir MaqboolGood Laboratory Practices Mubashir Maqbool
Good Laboratory Practices Mubashir Maqbool
 
GOOD LABORATORY PRACTICES
GOOD LABORATORY PRACTICES GOOD LABORATORY PRACTICES
GOOD LABORATORY PRACTICES
 
Good laboratory practices.pptx
Good laboratory practices.pptxGood laboratory practices.pptx
Good laboratory practices.pptx
 
good laboratory practices..docx
good laboratory practices..docxgood laboratory practices..docx
good laboratory practices..docx
 
Good Laboratory Practice (GLP)
Good Laboratory Practice (GLP) Good Laboratory Practice (GLP)
Good Laboratory Practice (GLP)
 
Good laboratory practice
Good laboratory practiceGood laboratory practice
Good laboratory practice
 
Good Laboratory Practices .pptx
Good Laboratory Practices .pptxGood Laboratory Practices .pptx
Good Laboratory Practices .pptx
 
Glp
GlpGlp
Glp
 
Good Laboratory Practice
Good Laboratory PracticeGood Laboratory Practice
Good Laboratory Practice
 
Good laboratory practices (GLP) himanshu
Good laboratory practices (GLP) himanshuGood laboratory practices (GLP) himanshu
Good laboratory practices (GLP) himanshu
 
Good Laboratory Practices Pharmaceutical Quality Assurance
Good Laboratory Practices Pharmaceutical Quality AssuranceGood Laboratory Practices Pharmaceutical Quality Assurance
Good Laboratory Practices Pharmaceutical Quality Assurance
 
OECD PRINCIPLES OF GLP- AKSHAY S.pptx
OECD PRINCIPLES OF GLP- AKSHAY S.pptxOECD PRINCIPLES OF GLP- AKSHAY S.pptx
OECD PRINCIPLES OF GLP- AKSHAY S.pptx
 

Recently uploaded

ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptPradnya Wadekar
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfDolisha Warbi
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationMedicoseAcademics
 
World-TB-Day-2023_Presentation_English.pptx
World-TB-Day-2023_Presentation_English.pptxWorld-TB-Day-2023_Presentation_English.pptx
World-TB-Day-2023_Presentation_English.pptxsumanchaulagain3
 
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.aarjukhadka22
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.pptRamDBawankar1
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communicationskatiequigley33
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxMAsifAhmad
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu Medical University
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxkomalt2001
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyMedicoseAcademics
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondSujoy Dasgupta
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024EwoutSteyerberg1
 
Good Laboratory Practice (GLP) in Pharma-LikeWays.pptx
Good Laboratory Practice (GLP) in Pharma-LikeWays.pptxGood Laboratory Practice (GLP) in Pharma-LikeWays.pptx
Good Laboratory Practice (GLP) in Pharma-LikeWays.pptxLikeways
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyZurück zum Ursprung
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfHongBiThi1
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptPradnya Wadekar
 
Physiotherapy Management of Rheumatoid Arthritis
Physiotherapy Management of Rheumatoid ArthritisPhysiotherapy Management of Rheumatoid Arthritis
Physiotherapy Management of Rheumatoid ArthritisNilofarRasheed1
 
introduction to neurology (nervous system, areas, motor and sensory systems)
introduction to neurology (nervous system, areas, motor and sensory systems)introduction to neurology (nervous system, areas, motor and sensory systems)
introduction to neurology (nervous system, areas, motor and sensory systems)Mohamed Rizk Khodair
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .Mohamed Rizk Khodair
 

Recently uploaded (20)

ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologyppt
 
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdfCONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
CONNECTIVE TISSUE (ANATOMY AND PHYSIOLOGY).pdf
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
 
World-TB-Day-2023_Presentation_English.pptx
World-TB-Day-2023_Presentation_English.pptxWorld-TB-Day-2023_Presentation_English.pptx
World-TB-Day-2023_Presentation_English.pptx
 
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
Bulimia nervosa ( Eating Disorders) Mental Health Nursing.
 
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D.  Bawankar.pptPharmacokinetic Models by Dr. Ram D.  Bawankar.ppt
Pharmacokinetic Models by Dr. Ram D. Bawankar.ppt
 
Using Data Visualization in Public Health Communications
Using Data Visualization in Public Health CommunicationsUsing Data Visualization in Public Health Communications
Using Data Visualization in Public Health Communications
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
 
historyofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusanguhistoryofpsychiatryinindia. Senthil Thirusangu
historyofpsychiatryinindia. Senthil Thirusangu
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptx
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before Pregnancy
 
Male Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and BeyondMale Infertility, Antioxidants and Beyond
Male Infertility, Antioxidants and Beyond
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024
 
Good Laboratory Practice (GLP) in Pharma-LikeWays.pptx
Good Laboratory Practice (GLP) in Pharma-LikeWays.pptxGood Laboratory Practice (GLP) in Pharma-LikeWays.pptx
Good Laboratory Practice (GLP) in Pharma-LikeWays.pptx
 
How to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturallyHow to cure cirrhosis and chronic hepatitis naturally
How to cure cirrhosis and chronic hepatitis naturally
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
 
Unit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.pptUnit I herbs as raw materials, biodynamic agriculture.ppt
Unit I herbs as raw materials, biodynamic agriculture.ppt
 
Physiotherapy Management of Rheumatoid Arthritis
Physiotherapy Management of Rheumatoid ArthritisPhysiotherapy Management of Rheumatoid Arthritis
Physiotherapy Management of Rheumatoid Arthritis
 
introduction to neurology (nervous system, areas, motor and sensory systems)
introduction to neurology (nervous system, areas, motor and sensory systems)introduction to neurology (nervous system, areas, motor and sensory systems)
introduction to neurology (nervous system, areas, motor and sensory systems)
 
Neurological history taking (2024) .
Neurological  history  taking  (2024)  .Neurological  history  taking  (2024)  .
Neurological history taking (2024) .
 

Oecd principles of GLP

  • 1. Major Advisor : Dr. K. Jayakumar Speaker : Amol R. Padol CREDIT SEMINAR-I
  • 3. OECD ??? o an intergovernmental organisation. o Representatives of 30 industrialised countries in North America, Europe, Pacific and the European Commission. o To co-ordinate and harmonize policies, discuss issues of mutual concern, and work together to respond to international problems.
  • 4. o Environmental Health and Safety Division. o The Principles of GLP have been developed to promote the quality and validity of test data used for determining the safety of chemicals and chemical products (Schechtman, 2007)
  • 5. Good Laboratory PracticeGood Laboratory Practice o A quality system concerned with the organisational process and the conditions under which non-clinical health and environmental safety studies are planned, performed, monitored, recorded, archived and reported. (OECD/ENV/MC/CHEM,1998)
  • 6. o Its principles are required to be followed by test facilities carrying out studies to be submitted to national authorities. o Common principles for GLP facilitate the exchange of information and prevent the emergence of non-tariff barriers to trade. (Berend, 2002)
  • 7. o The issue of data quality has an important international dimension. o If regulatory authorities in countries can rely on safety test data developed abroad, duplicative testing can be avoided.
  • 9. o The GLP regulations for non-clinical laboratory studies published by the US-FDA in 1976 (Baldeshwiler, 2003). o The OECD Principles of GLP were first developed by an Expert Group on GLP established in 1978 under the Special Programme on the Control of Chemicals. o Principles of GLP were adopted by the OECD in 1981.
  • 10. o Expert Group was established in 1995 to develop a proposal to revise the Principles of GLP. o The Revised OECD Principles of GLP were reviewed in the relevant policy bodies of the Organisation and were adopted by Council on 26 November, 1997. o Indian GLP Compliance Monitoring Authority - April, 2002.
  • 12.  Principles of GLP should be applied to the non-clinical safety testing of test items contained in,  Pharmaceutical products  Pesticide products  Cosmetic products  Veterinary drugs  Food and feed additives  Industrial chemicals.
  • 13. o Test items: synthetic chemicals, natural or biological origin and, may be living organisms. o Safety studies covered by the Principles of GLP include work conducted in the laboratory, in greenhouses, and in the field (Jena et al ., 2009) o Principles of GLP apply to all non-clinical health and environmental safety studies required by regulations for the purpose of registration.
  • 16. Test Facility Management o The person(s) who has the authority and formal responsibility for the organisation and functioning of the test facility. Responsibilities o Maintenance of a record of the qualifications, training, experience and job description for each professional and technical individual.
  • 17. o Appropriate and technically valid SOPs are established and followed. o Quality Assurance Programme is being performed in accordance with the Principles of GLP. o Individual with the appropriate qualifications, training, and experience is designated by the management as the Study Director before the study is initiated.
  • 18. o In the event of a multi-site study, a Principal Investigator is designated. o Test Facility Management should ensure the documented approval of the study plan by the Study Director. o Ensure that the SD has made the approved study plan available to the QA personnel.
  • 19. o An individual is identified as responsible for the management of the archive(s). o For a multi-site study clear lines of communication should exist between the SD, Principal Investigator(s), the QAP(s) and study personnel. o Computerised systems should be validated, operated and maintained in accordance with Principles of GLP (Udaka and Horii, 1985)
  • 20. Study Director o The individual responsible for the overall conduct of the nonclinical health and environmental safety study. o The single point of study control.
  • 21. o Approve the study plan and any amendments by dated signature. o SD should ensure that the QA personnel have a copy of the study plan and any amendments. o Study plans (and amendments) and SOPs are available to study personnel. Responsibilities of SD
  • 22. o SD should ensure that all raw data generated are fully documented and recorded. o Computerised systems used in the study should be validated (Taylor, 1984) o SD should sign and date the final report to indicate acceptance of responsibility for the validity of the data.
  • 23. o SD should ensure that after completion of the study,  the study plan  the final report  raw data  supporting material are archived.
  • 24. Principal Investigator o an individual who, for a multi- site study, acts on behalf of the SD and has defined responsibility for delegated phases of the study. o The PI should ensure that the delegated phases of the study are conducted in accordance with the Principles of GLP.
  • 25. Responsibilities of Study Personnel o Knowledgeable in those parts of the Principles of GLP which are applicable to their involvement in the study. o Access to the study plan and appropriate SOPs. o Any deviation from these instructions should be documented and communicated directly to the SD, or the Principal Investigator.
  • 26. o Responsible for recording raw data promptly and accurately and for the quality of the data. o Study personnel should exercise health precautions to minimise risk to themselves and to ensure the integrity of the study (Schechtman, 2007).
  • 27. Quality Assurance Programme o "an internal control system designed to ascertain that the study is in compliance" with the Principles of GLP. o The test facility should have a documented QAP. o An individual or individuals designated by management, who are familiar with the test procedures (Hughes, 1999) o should not be involved in the conduct of the study being assured (Becker et al., 2009)
  • 28. o Maintain copies of all approved study plans and SOPs. o Verify that the study plan contains the information required for compliance with the Principles of GLP. o Conduct inspections to determine that all studies are conducted in accordance with the Principles of GLP. (Hughes, 1999) Responsibilities of the QA- Personnel
  • 29. o Inspect the final reports to confirm that,  the methods, procedures and observations are accurately and completely described.  reported results accurately and completely reflect the raw data of the studies.
  • 30. o Promptly report any inspection results in writing to management and to the SD, or Principal Investigator(s). o Prepare and sign a statement, which specifies types of inspections and their dates, including the phase(s) of the study inspected.
  • 31. Facilities o Suitable size, construction and location to meet the requirements of the study. o Adequate degree of separation of the different activities to assure the proper conduct of each study (Garner and Barge, 1989)
  • 32. Facilities for Handling Test and Reference Items o Separate areas for receipt and storage of the test and reference items, and mixing of the test items with a vehicle. o Storage areas for the test items should be separate from areas containing the test systems. o Storage areas should be adequate to preserve identity, concentration, purity, and stability.
  • 33. Archive Facilities o Archive facilities should be provided for the secure storage and retrieval of study plans, raw data, final reports, samples of test items and specimens. Archive design and archive conditions should protect contents from untimely deterioration (Udaka and Horii, 1985)
  • 34. Waste Disposal o Handling and disposal of wastes should be carried out in such a way as not to jeopardize the integrity of studies. o Provision for appropriate collection, storage and disposal facilities, and decontamination and transportation procedures.
  • 35. Apparatus, Material and Reagents o Apparatus should be suitably located and of appropriate design and adequate capacity. o Periodically inspected, cleaned, maintained, and calibrated according to SOPs. o Apparatus and materials used in a study should not interfere adversely with the test systems (Stevenson, 1992)
  • 36. o Chemicals, reagents, and solutions should be labelled to indicate identity, expiry date and specific storage instructions. o Information concerning source, preparation date and stability should be available.
  • 37. Test SystemsTest Systems o any biological, chemical or physical system or a combination thereof used in a study. Physical/ChemicalPhysical/Chemical  Location  Design  Capacity.
  • 38. o Proper conditions should be established and maintained for the storage, housing, handling and care of biological test systems. o Newly received animal and plant test systems should be isolated until their health status has been evaluated. o Acclimatised to the test environment. Biologica l
  • 39. Standard Operating Procedures o A test facility should have written SOPs approved by test facility management. o Language interpretable to those who are going to use them (Federick, 2006) Documented procedures which describe how to perform tests or activities normally not specified in detail in study plans or test guidelines.
  • 40. o Deviations from SOPs should be documented and acknowledged by the SD or the Principal Investigator. o Published text books, analytical methods, articles and manuals -supplements to the SOPs. o Reviewed regularly.
  • 41. o SOPs should be available for the following categories of activities:  Test and Reference Items  Apparatus, Materials and Reagents  Record Keeping, Reporting, Storage, and Retrieval  Test System  Quality Assurance Procedures.
  • 42. Content of the Study Plan o Identification of the study, the test item and reference item. o Information concerning the sponsor and the test facility. o Dates o Test Methods o Records
  • 43. Conduct of the Study o A unique identification should be given to each study, all items concerning this study should carry this identification (Royal, 1994) o Specimens from the study should be identified to confirm their origin. o Conducted in accordance with the study plan.
  • 44. o Data generated should be recorded directly, promptly, accurately and signed and dated. o Any change in the raw data should indicate the reason for change and should be dated and signed by the individual making the change. o Computerised system should always provide for the retention of full audit trails to show all changes to the data without obscuring the original data.
  • 45. Reporting of Study Results o The final report should be signed and dated by the SD to indicate acceptance of responsibility for the validity of the data. o The extent of compliance with the principles of GLP should be indicated. o Amendments should clearly specify the reason for the corrections or additions and should be signed and dated by the SD (Ranade, 2007)
  • 46. Content of the Final Report o The final report should include,  Identification of the Study, the Test Item and Reference Item.  Information concerning the Sponsor and the Test Facility.  Dates  QAP statement  Description of Test Methods  Results  Storage (study plan, test and reference items, specimens, raw data)
  • 47. Mutual Acceptance of Data o Testing of chemicals is labour-intensive and expensive, and testing the same chemical in several countries adds to the cost in time, resources and laboratory animals. o To relieve some of this burden, the OECD Council adopted the concept of MAD in 1981.
  • 48. o Mutual Acceptance of Data: “Data generated in a member country in accordance with OECD Test Guidelines and Principles of GLP shall be accepted in other member countries for assessment purposes and other uses relating to the protection of human health and the environment.” (Turnheim , 2008)
  • 49. o OECD Council sets out a step-wise procedure for non- OECD countries with a major chemical industry to take part in the work of OECD (Sasaki et al., 2009) o This leads to full membership in the part of OECD related to the MAD. o South Africa was the first non-OECD country to have completed this process and to have been invited to join the system as a full member.
  • 50. o Slovenia and Israel - full members. o Argentina, Brazil, India (2003) , Malaysia and Singapore are the provisional adherents. o The provisional adherence procedures have begun for Thailand.
  • 51. National GLP Compliance Monitoring Authority (NGCMA) o April, 2002 o Department of Science and Technology (DST). o Provisional Member of the OECD for GLP. o Head, National GLP Programme has been nominated by the Department as an Observer to the OECD’s Working Group on GLP. o functions as per OECD Norms & Principles and efforts are being made to achieve OECD recognition, so that India acquires full-member status in OECD (Stanley, 2009) There is still long way to go……………..!
  • 53. o The purpose of GLP is to assure the quality and integrity of data submitted in support of the safety of regulated products. o Protocols, SOPs, adequate facilities, and equipments, identification of test substance, proper animal care, accurate recording of observations and adequate reporting of results are basic necessities for the conduct of high quality valid toxicity study.
  • 54. o Test results obtained in compliance with GLP are to be mutually accepted by the health authorities and environment authorities of the OECD member states. Therefore, multiple testing can be avoided.